Comparison of the TOF-Cuff NMT Monitor to the TOF-Watch SX acceleromyograph for perioperative neuromuscular monitoring.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON25935

Enrollment

Registered

2017-12-24

Start date

2018-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neuromuscular monitoring, TOF-Cuff, TOF-Watch

Interventions

Perioperative neuromuscular monitoring with both the TOF-Cuff NMT Monitor and the TOF-Watch SX acceleromyograph.

Eligibility

Inclusion criteria

Inclusion criteria: 15 patients, age >18 years, American Society of Anesthesiologists physical status I-III, undergoing elective surgery in supine position with both arms abducted, under general anesthesia with orotracheal intubation aided by administration of a non-depolarizing neuromuscular blocking agent.

Exclusion criteria

Exclusion criteria: - No informed consent - Neuromuscular disease. - Diabetes Mellitus - Indication for rapid sequence induction - Expected difficult intubation or ventilation - Pregnancy - Allergy to neuromuscular blocking agent (rocuronium)

Design outcomes

Primary

Measure	Time frame
the bias and limits of agreement of the TOF-Cuff NMT Monitor and the TOF-Watch SX acceleromyograph for perioperative neuromuscular monitoring	—

Secondary

Measure	Time frame
the bias and limits of agreement of the TOF-Cuff NMT Monitor and the TOF-Watch SX acceleromyograph for perioperative neuromuscular monitoring?	—

Contacts

Public ContactP. Krijtenburg

piet.krijtenburg@radboudumc.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)